← brief for 2026-10-31 · Slowing decline

Adjunctive fucoidan, fucoxanthin, and l-carnitine mitigate albuminuria and preserve eGFR over a 12-week treatment period in diabetic kidney disease: A translational study and proof-of-concept randomized clinical trial.

Key takeaways

A small trial of 63 people with diabetic kidney disease tested a marine supplement. Over 12 weeks, the supplement helped keep kidney function stable. It also reduced protein in the urine. This is a small test, so more proof is needed.

Who did this work

Chen CH · Chang TI · Chen CY · Lu DE · Chu YL · Huang NJ · Cheng CY · Chen TH · Hsieh HL · Liu CT

Source

Article · PubMed, the drug frontier · 2026 Oct 21
https://pubmed.ncbi.nlm.nih.gov/42966155/